Notably, intervention with AAV8-scFv-E06 protected mice with established hepatic steatosis from further liver injury as evidenced by significantly reduced plasma AST (Fig. 5D), ALT (Fig. 5E), ALP (Fig. 5F), LDL:HDL ratio (fig. This evidence concerns the gene GPT and fatty liver disease.